Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
about
Risk evaluation and monitoring in multiple sclerosis therapeutics.Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0)--Development of an Outcome Instrument for Educational Interventions.Assessing understanding of individual risk and symptoms of progressive multifocal leukoencephalopathy in patients prescribed natalizumab for multiple sclerosis.Perception of risk and shared decision making process in multiple sclerosis.Risk perception, self-efficacy, trust for physician, depression, and behavior modification in diabetic patients.
P2860
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@en
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@nl
type
label
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@en
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@nl
prefLabel
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@en
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@nl
P2093
P2860
P356
P1476
Long-term treatment risks in m ...... mitoxantrone-treated patients.
@en
P2093
J P Stellmann
J Repenthin
MS Network Hamburg
T Rosenkranz
P2860
P304
P356
10.1177/1352458512461967
P577
2012-10-04T00:00:00Z